Homelessness and Psychological Distress as Contributors to Antiretroviral Nonadherence in HIV-Positive Injecting Drug Users
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
High levels of adherence to antiretroviral medications are required to maximize therapeutic benefits and viral suppression. Injecting drug use (IDU) is associated with decreased adherence levels, unstable living conditions and mental health problems. Despite the prevalence of these nonadherence risks in HIV-positive IDUs, little study has been conducted to date to assess the impact of homelessness and psychological distress on adherence in this population. The present study evaluated the effects of housing status (homeless/marginally housed versus nonhomeless) and psychological distress, measured via depression, anxiety and perceived stress, on self-reported adherence in 58 HIV-positive IDUs. Results from this study indicated that homeless/marginally housed HIV-positive IDUs reported higher levels of anxiety and perceived stress than their nonhomeless counterparts. The groups reported similar levels of depression. However, only depression was significantly related to adherence. Housing status, drug or alcohol use, and other demographic variables including gender, race/ethnicity, and years of education, were not associated with adherence. This study also found a relatively high rate of adherence in homeless/marginally housed IDUs with more than half (63%) reporting perfect (100%) adherence levels. Findings from this study suggest that when evaluating patient readiness for antiretroviral medications, current housing may not need to be the primary concern. Rather, depression may be a more potent indicator of nonadherence than homelessness for HIV-positive IDUs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2101 · Cited by 4,177
Reynolds, N. R., Testa, M. A., Marc, L. G., Chesney, M. A., Neidig, J. L., Smith, S. R., Vella, S., Robbins, G. K., & Protocol Teams of ACTG 384, A. 7. (2004) · AIDS and Behavior · doi:10.1023/b:aibe.0000030245.52406.bb · Cited by 204 · cited 1×
“35 Stress can also interfere with one’s coping abilities, HOMELESSNESS, DISTRESS, AND NONADHERENCE 331 thus reducing quality of life in HIV infection.”
Cited by
Depression and HIV/AIDS Treatment Nonadherence: A Review and Meta-analysis
Gonzalez, J. S., Batchelder, A. W., Psaros, C., & Safren, S. A. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31822d490a · Cited by 779
Aidala, A. A., Wilson, M. G., Shubert, V., Gogolishvili, D., Globerman, J., Rueda, S., Bozack, A. K., Caban, M., & Rourke, S. B. (2016) · American Journal of Public Health · doi:10.2105/ajph.2015.302905 · Cited by 418
Chander, G., Himelhoch, S., & Moore, R. D. (2006) · Drugs · doi:10.2165/00003495-200666060-00004 · Cited by 379
Malta, M., Strathdee, S. A., Magnanini, M. M. F., & Bastos, F. I. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02269.x · Cited by 283
Milloy, M.-J., Kerr, T., Bangsberg, D. R., Buxton, J., Parashar, S., Guillemi, S., Montaner, J., & Wood, E. (2012) · AIDS Patient Care and STDs · doi:10.1089/apc.2011.0169 · Cited by 112
Grodensky, C. A., Golin, C. E., Ochtera, R. D., & Turner, B. J. (2012) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2012.73.899 · Cited by 100
Prevalence, impact, and management of depression and anxiety in patients with HIV: a review
Chaudhury, S., Bakhla, A., & Saini, R. (2016) · Neurobehavioral HIV Medicine · doi:10.2147/nbhiv.s68956 · Cited by 54
“134 It has been suggested that baseline depression does not influence treatment adherence, as it is affected by incident depression during the treatment period.”
Metadata
- Authors
- Waldrop-Valverde, D., & Valverde, E.
- Venue
- AIDS Patient Care and STDs
- Publisher
- SAGE Publications
- Published
- 2005-05
- Volume
- 19
- Issue
- 5
- Pages
- 326-334
- ISSN
- 1087-2914 (ISSN-L)
- 1557-7449
- OpenAlex
- W2090400148
- Cited by
- 80
- References
- 2
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.